» Articles » PMID: 10680026

Dipyridamole-induced Reversible Thallium-201 Defect in Patients with Vasospastic Angina and Nearly Normal Coronary Arteries

Overview
Journal Clin Cardiol
Date 2000 Feb 19
PMID 10680026
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Dipyridamole is a vasodilator of resistance vessels and has no vasoconstrictive effect on large coronary arteries.

Hypothesis: The present study used dipyridamole thallium-201 (201Tl) scintigraphy to clarify the role of microvasculature in coronary flow limitation in patients with vasospastic angina and normal coronary arteries.

Methods: Sixteen patients underwent dipyridamole and exercise 201Tl scintigraphy and provocative coronary angiography with acetylcholine. All patients showed coronary spasm (> 90% vasoconstriction concomitant with ST change) in at least one vessel.

Results: Dipyridamole or exercise caused only ST depression despite the ST elevation observed at spontaneous attack. Dipyridamole 201Tl scintigraphy demonstrated the reversible defects (11 cases), as did exercise 201Tl scintigraphy (13 cases). The region of 201Tl defect was not always consistent with the territories of angiographically depicted vasospastic arteries. Basal coronary tone, assessed by percentage of diameter change of epicardial arteries from baseline to isosorbide dinitrate administration, did not differ between the positive and the negative defect regions.

Conclusion: These results support the hypothesis that, in addition to epicardial coronary spasm, the dysfunction of microvasculature is responsible for abnormal coronary perfusion in the subgroup of patients with vasospastic angina and normal coronary arteries.

Citing Articles

Non-invasive diagnosis of vasospastic angina.

Ngo V, Tavoosi A, Natalis A, Harel F, Jolicoeur E, Beanlands R J Nucl Cardiol. 2022; 30(1):167-177.

PMID: 35322379 DOI: 10.1007/s12350-022-02948-z.


Coronary vasospasm produces reversible perfusion defects observed during adenosine triphosphate stress myocardial single-photon emission computed tomography.

Teragawa H, Ueda K, Okuhara K, Kuwashima R, Fukuda Y, Kiguchi M Clin Cardiol. 2008; 31(7):310-6.

PMID: 18636477 PMC: 6653485. DOI: 10.1002/clc.20217.


Coronary steal and ST elevation during dipyridamole stress testing leading to coronary artery bypass grafting.

Mutlu H, Leppo J J Nucl Cardiol. 2007; 14(6):892-7.

PMID: 18022117 DOI: 10.1016/j.nuclcard.2007.09.004.

References
1.
Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S . Circadian variation of exercise capacity in patients with Prinzmetal's variant angina: role of exercise-induced coronary arterial spasm. Circulation. 1979; 59(5):938-48. DOI: 10.1161/01.cir.59.5.938. View

2.
Yokoyama M, Akita H, Hirata K, Usuki S, Fukuzaki H, Itoh H . Supersensitivity of isolated coronary artery to ergonovine in a patient with variant angina. Am J Med. 1990; 89(4):507-15. DOI: 10.1016/0002-9343(90)90383-o. View

3.
Okumura K, Yasue H, Goto K, Miyagi H, Ogawa H, Matsuyama K . Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol. 1988; 12(4):883-8. DOI: 10.1016/0735-1097(88)90449-4. View

4.
Kinsella D, Troup W, McGregor M . Studies with a new coronary vasodilator drug: persantin. Am Heart J. 1962; 63:146-51. DOI: 10.1016/0002-8703(62)90190-4. View

5.
Holdright D, Lindsay D, Clarke D, Fox K, Poole-Wilson P, Collins P . Coronary flow reserve in patients with chest pain and normal coronary arteries. Br Heart J. 1993; 70(6):513-9. PMC: 1025381. DOI: 10.1136/hrt.70.6.513. View